Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02457338 · ClinicalTrials.gov registry record · NA

Infant Microbiota and Probiotic Intake Study

A NA study of Healthy, sponsored by University of California, Davis.

Active
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT02457338 is a NA study of Healthy that is active but no longer recruiting, run by University of California, Davis. The registered enrollment target is 120 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02457338, a NA study of Healthy, is active but no longer recruiting, sponsored by University of California, Davis.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if supplementing healthy term infants delivered by C-section or vaginal delivery who only consume breastmilk with a probiotic for 21 consecutive days increases levels of bacteria in infants' stool.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Bifidobacterium

Study Locations (1)

California

  • University of California, Davis Medical Center - Sacramento

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2014-11-01
Est. Completion 2027-06-07
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT02457338

The ClinicalTrials.gov registry entry for NCT02457338 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (81% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Bifidobacterium is the first listed.

NCT02457338 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02457338 about?

NCT02457338 is a clinical study titled "Infant Microbiota and Probiotic Intake Study". The purpose of this study is to determine if supplementing healthy term infants delivered by C-section or vaginal delivery who only consume breastmilk with a probiotic for 21 consecutive days increases levels of bacteria in infants' stool.

What is the current status of trial NCT02457338?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2014-11-01. Estimated completion is 2027-06-07.

What conditions does trial NCT02457338 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT02457338?

The interventions under investigation include: Bifidobacterium (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02457338?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02457338 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.